The Barclays PLC Reaffirms “Overweight” Rating for Aetna Inc (AET)

The Barclays PLC Reaffirms “Overweight” Rating for Aetna Inc (AET)

A number of other equities research analysts also recently commented on the stock. Cantor Fitzgerald reissued a “buy” rating and issued a $150.00 price objective on shares of Aetna in a research report on Friday, May 12th. Cleveland Research raised shares of Aetna from a “neutral” rating to a “buy” rating in a research report on Thursday, May 11th. Jefferies Group LLC reissued a “hold” rating and issued a $140.00 price objective (up from $133.00) on shares of Aetna in a research report on Wednesday, May 3rd. Stifel Nicolaus reissued a “buy” rating and issued a $150.00 price objective (up from $130.00) on shares of Aetna in a research report on Wednesday, May 3rd. Finally, Royal Bank of Canada reissued a “buy” rating and issued a $145.00 price objective on shares of Aetna in a research report on Monday, April 24th. Eight analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company’s stock. Aetna presently has an average rating of “Buy” and an average target price of $146.27.

Aetna Inc (NYSE:AET)‘s stock had its “overweight” rating restated by stock analysts at Barclays PLC in a research note issued to investors on Monday, May 15th. They presently have a $162.00 target price on the stock. Barclays PLC’s target price would indicate a potential upside of 9.66% from the stock’s current price.

Shares of Aetna (AET) opened at 147.73 on Monday. Aetna has a 52 week low of $104.59 and a 52 week high of $148.70. The firm has a market capitalization of $49.00 billion, a P/E ratio of 45.05 and a beta of 0.61. The firm has a 50-day moving average of $139.34 and a 200 day moving average of $129.59.

Aetna (NYSE:AET) last announced its quarterly earnings data on Tuesday, May 2nd. The company reported $2.71 EPS for the quarter, beating the Zacks’ consensus estimate of $2.36 by $0.35. Aetna had a net margin of 3.58% and a return on equity of 16.39%. The company had revenue of $15.17 billion for the quarter, compared to the consensus estimate of $15.39 billion. During the same period in the prior year, the firm posted $2.30 EPS. The company’s quarterly revenue was down 3.4% compared to the same quarter last year. On average, equities research analysts expect that Aetna will post $8.99 EPS for the current fiscal year. The firm also recently declared a quarterly dividend, which will be paid on Friday, July 28th. Investors of record on Thursday, July 13th will be paid a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 1.35%. The ex-dividend date is Tuesday, July 11th. Aetna’s dividend payout ratio is currently 15.67%.

Aetna (NYSE:AET) last announced its quarterly earnings data on Tuesday, May 2nd. The company reported $2.71 EPS for the quarter, beating the Zacks’ consensus estimate of $2.36 by $0.35. Aetna had a net margin of 3.58% and a return on equity of 16.39%. The company had revenue of $15.17 billion for the quarter, compared to the consensus estimate of $15.39 billion. During the same period in the prior year, the firm posted $2.30 EPS. The company’s quarterly revenue was down 3.4% compared to the same quarter last year. On average, equities research analysts expect that Aetna will post $8.99 EPS for the current fiscal year. In other Aetna news, insider Shawn M. Guertin sold 29,602 shares of the company’s stock in a transaction on Thursday, March 23rd. The shares were sold at an average price of $129.35, for a total transaction of $3,829,018.70. Following the completion of the transaction, the insider now owns 44,880 shares in the company, valued at approximately $5,805,228. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, VP Francis S. Soistman, Jr. sold 6,607 shares of the company’s stock in a transaction on Wednesday, March 8th. The stock was sold at an average price of $131.98, for a total transaction of $871,991.86. Following the transaction, the vice president now owns 23,454 shares of the company’s stock, valued at approximately $3,095,458.92. The disclosure for this sale can be found here. In the last quarter, insiders have sold 139,756 shares of company stock valued at $19,279,393. 0.90% of the stock is owned by company insiders.

A number of institutional investors have recently made changes to their positions in AET. Guardian Life Insurance Co. of America increased its position in shares of Aetna by 0.7% in the first quarter. Guardian Life Insurance Co. of America now owns 1,353 shares of the company’s stock worth $173,000 after buying an additional 9 shares during the last quarter. Concert Wealth Management Inc. increased its position in shares of Aetna by 0.4% in the first quarter. Concert Wealth Management Inc. now owns 3,262 shares of the company’s stock worth $405,000 after buying an additional 14 shares during the last quarter. Simmons Bank increased its position in shares of Aetna by 0.8% in the third quarter. Simmons Bank now owns 1,920 shares of the company’s stock worth $221,000 after buying an additional 15 shares during the last quarter. National Asset Management Inc. increased its position in shares of Aetna by 0.8% in the third quarter. National Asset Management Inc. now owns 2,550 shares of the company’s stock worth $296,000 after buying an additional 20 shares during the last quarter. Finally, CAPROCK Group Inc. increased its position in shares of Aetna by 0.9% in the first quarter. CAPROCK Group Inc. now owns 2,824 shares of the company’s stock worth $360,000 after buying an additional 25 shares during the last quarter. Institutional investors own 88.40% of the company’s stock. About Aetna

Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.new TradingView.widget({ “height”: 400, “width”: 625, “symbol”: “AET”, “interval”: “D”, “timezone”: “Etc/UTC”, “theme”: “White”, “style”: “1”, “locale”: “en”, “toolbar_bg”: “#f1f3f6”, “enable_publishing”: false, “hideideas”: true, “referral_id”: “2588”});

Related posts

Leave a Comment